Aadi Bioscience, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Aadi Bioscience, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Aadi Bioscience, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $72.1M, a 36.7% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $72.1M +$19.4M +36.7% Dec 31, 2023 10-K 2024-03-13
Q4 2022 $52.8M +$14.4M +37.4% Dec 31, 2022 10-K 2024-03-13
Q4 2021 $38.4M +$28.2M +275% Dec 31, 2021 10-K 2023-03-29
Q4 2020 $10.3M -$20.5M -66.6% Dec 31, 2020 10-K 2022-03-17
Q4 2019 $30.7M +$5.74M +22.9% Dec 31, 2019 10-K 2021-03-11
Q4 2018 $25M +$2.83M +12.8% Dec 31, 2018 10-K 2020-03-16
Q4 2017 $22.2M -$3.77M -14.5% Dec 31, 2017 10-K 2019-03-07
Q4 2016 $25.9M +$25.9M +32169% Dec 31, 2016 10-K 2018-03-15
Q4 2015 $80.4K +$10.6K +15.2% Dec 31, 2015 10-K 2017-03-07
Q4 2014 $69.8K +$10.6K +17.9% Dec 31, 2014 10-K 2016-03-30
Q4 2013 $59.2K +$9.8K +19.8% Dec 31, 2013 10-K 2015-02-27
Q4 2012 $49.4K +$9.2K Dec 31, 2012 10-K 2014-03-31
Q4 2011 $40.2K* Dec 31, 2011 10-K 2013-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.